Hodgkin disease: Prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy

Radiology

Volumn 210, Issue 2, 1999, Pages 487-491

  Front, Dov ^a   Bar Shalom, Rachel ^a   Mor, Maya ^a   Haim, Nissim ^a   Epelbaum, Ron ^a   Frenkel, Alex ^a   Gaitini, Diana ^a   Kolodny, Gerald M ^a   Israel, Ora ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Emission CT (ECT); Gallium, radioactive; Hodgkin disease; Lymphatic system, neoplasms; Lymphoma, radionuclide studies

Indexed keywords

BLEOMYCIN SULFATE; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; GALLIUM CITRATE GA 67; PREDNISONE; PROCARBAZINE; VINBLASTINE SULFATE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

EID: 0032954304     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.210.2.r99fe07487     Document Type: Article

References (19)

1. Fabian CJ, Mansfield CM, Dahlberg S, et al. Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: a Southwest Oncology Group randomized study. Ann Intern Med 1994; 120:903-912.
2. Israel O, Front D, Lam M, et al. Gallium-67 imaging in monitoring lymphoma response to treatment. Cancer 1988; 61:2439-2443.
3. Front D, Israel O, Epelbaum R, et al. Ga-67 SPECT before and after treatment of lymphoma. Radiology 1990; 175:515-519.
4. Front D, Ben-Haim S, Israel O, et al. Lymphoma: predictive value of Ga-67 scintigraphy after treatment. Radiology 1992; 182:359-363.
5. Kaplan WD, Jochelson MS, Herman TS, et al. Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphomas. J Clin Oncol 1990; 8:1966-1970.
6. King SC, Reiman RJ, Prosnitz LR, et al. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease. J Clin Oncol 1994; 12:306-311.
7. Kostakoglu L, Yeh SDJ, Portlock C, et al. Validation of gallium-67 citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med 1992; 33:345-350.
8. Salloum E, Schwab Brandt D, Caride VJ, et al. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients. J Clin Oncol 1997; 15:518-527.
9. Front D, Israel O. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Semin Nucl Med 1995; 25:60-71.
10. Bar-Shalom R, Israel O, Haim N, et al. Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance? Radiology 1996; 199:473-476.
11. Even-Sapir E, Bar-Shalom R, Israel O, et al. Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake. J Clin Oncol 1995; 13:942-946.
12. 3]deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 1985; 26:278-282.
13. Shipp MA, Harrington DP. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329:987-994.
14. Shipp MA. Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease? Blood 1994; 83:1165-1173.
15. Shipp MA, Neuberg D, Canellos GP. Highdose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. J Clin Oncol 1995; 13:2916-2923.
16. Haq R, Sawka CA, Franssen E, et al. Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review. J Clin Oncol 1994; 12:1074-1084.
17. Armitage JO, Wisenhurger DD, Hutchins M, et al. Chemotherapy for diffuse large cell lymphoma: rapidly responding patients have more durable remissions. J Clin Oncol 1986; 4:160-164.
18. Link MP, Shuster JJ, Donaldson SS, et al. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med 1997; 337:1259-1266.
19. Magrath I. Limiting therapy for limited childhood non-Hodgkin's lymphoma. N Engl J Med 1997; 337:1304-1305.